Developer docs
API playgroundTry for free, no card

Search company profiles

JUNGJIN International Intellectual Property Law Firm

Full company profile

uuid004oxmu

Namestring
JUNGJIN International Intellectual Property Law Firm
Legal namestring
특허법인 정진
Websiteurl
jjpat.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

JUNGJIN International Intellectual Property Law Firm (특허법인 정진) is a Seoul-based intellectual property law firm founded in 2006 by Managing Partner Kim Soon-woong, a former Director of Technology Transfer at Seoul National University R&DB Foundation. The firm specializes in patent and trademark prosecution, IP-R&D strategic consulting, Freedom-to-Operate (FTO) analysis, technology valuation, and technology transfer commercialization. Approximately 72% of its practice is concentrated in the biotechnology and pharmaceutical sectors, and roughly 80% of clients are universities, national research institutes, startups, and SMEs. Since inception, the firm has handled more than 12,000 patent and trademark filings and has sustained technology transfer outcomes exceeding KRW 1 billion annually since 2016, with notable transactions including the 2021 KRIBB NK Cell technology transfer valued at KRW 150 billion and the 2026 Ajou University-RESPIRA Singapore licensing deal for AI-based inhalation capsule technology.

The firm's service portfolio is organized around five practice areas: Patent Prosecution, Overseas/PCT Filing, Litigation/Trials, IP-R&D Strategic Consulting, and Technology Licensing/Commercialization Consulting. It is differentiated by patent big-data-driven IP-R&D methodology, a multidisciplinary team of patent attorneys and technical specialists (veterinarians, pharmacists, biologists, chemists, and engineers), and a wholly-owned consulting subsidiary, the Jungjin IP Strategy Institute (정진지식재산전략연구소), established in 2020. The firm maintains anchor relationships with 40+ Korean universities and 10+ national research institutes and counts EuBiologics, CJ, SCD Pharmaceutical, Quratis, Asan Medical Center, Samsung Medical Center, KRIBB, and the National Marine Biodiversity Institute of Korea among its named clients.

Commercial operations are anchored in a single Seoul headquarters in Guro-gu, with revenue generated through engagement-based professional services fees, patent prosecution retainers, and success-based technology transfer and IP financial services. Marketing and lead generation are driven by thought-leadership columns in IP trade publications, a weekly pharma/biotech IP Issue Clip newsletter, and active participation in domestic and international events such as INTA, the INTERBIZ Bio Partnering Forum, and KAIPS bilateral IP forums. In November 2025, the firm was officially designated as a Technology Transfer Institution by the Minister of Trade, Industry and Energy, and it remains a registered consulting organization for the Korea IP Protection Agency's Pharmaceutical Patent Strategy Support Program (since 2022). Headcount has grown from 18 to 40+ professionals between the firmographic snapshot and late 2024/early 2025, with additional senior technical hires planned for 2026.

Short descriptiontext

JUNGJIN International Intellectual Property Law Firm is a Seoul-based IP law firm specializing in patent/trademark prosecution, IP-R&D consulting, FTO analysis, and technology transfer, serving biotech/pharma companies, universities, and research institutes across Korea.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patent prosecution services, IP strategy consulting, patent litigation, intellectual property law, technology transfer services
Industry4 codes
PRIMARYBPAHAMAA
Patent Prosecution & Portfolio Management
SECONDARYBPAHAMAF
IP Licensing, Transactions & Technology Transfer
SECONDARYBPAHAMAJ
IP Filing, Annuities & Renewals Administration
SECONDARYBPAHAMAI
IP Search, Watch & Competitive Intelligence
NAICS code1 code
  • Legal Services5411
SIC code1 code
  • Services-Legal Services8111
Product category
Intellectual Property Law Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Patent and Trademark Filing Services
TypeOne Time License
Description

Domestic and international patent, utility model, design, and trademark prosecution and registration services.

jjpat.com
2IP-R&D and Technology Commercialization Consulting
TypeProfessional Services
Description

Strategic IP consulting, FTO analysis, patent portfolio construction, and technology transfer services. Technology transfer outcomes have exceeded KRW 1 billion annually since 2016.

jjpat.com
3IP Financial Services
TypeLicensing Royalties
Description

Technology valuation, IP investment matching, M&A IP due diligence, and unused patent identification and transfer services.

jjpat.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

JUNGJIN is a Korean IP law firm providing full-cycle intellectual property services including domestic and international patent and trademark prosecution, PCT/overseas filing, IP litigation and trials, IP-R&D strategic consulting using patent big data analytics, and technology licensing and commercialization. The firm specializes in biotech and pharmaceutical sectors (72% of practice) and serves universities, national research institutes, and biotech/pharma companies with deep technical expertise and end-to-end IP support from R&D planning through technology transfer.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Technology transfer revenue exceeding KRW 1 billion annually since 2016
+3 more records
Product overview1 text field

JUNGJIN IP Law Firm is an IP services firm offering a comprehensive portfolio of intellectual property services organized around five core practice areas: Patent Prosecution, Overseas/PCT Filing, Litigation/Trials, IP-R&D Strategic Consulting, and Technology Licensing Consulting. The firm operates specialized teams across biotechnology, chemistry, mechanical engineering, electronics, trademarks, and design. Its subsidiary, the Jungjin IP Strategy Institute, provides advanced IP strategy consulting and operates alongside the law firm to deliver full-cycle IP solutions. The firm is particularly strong in bio/pharmaceutical IP (approximately 72% of practice) and was officially designated as a Technology Transfer Institution by the Ministry of Trade, Industry and Energy in November 2025, enabling it to lead IP-based technology transfer, commercialization, and activation.

Product and service6 records
1Patent Prosecution Services
CategoryPatent Services
Description

Comprehensive patent filing, prosecution, and registration services covering domestic and international patent applications. Provided to universities, research institutes, biotech/pharma companies, and SMEs.

2Overseas/PCT Filing Services
CategoryPatent Services
Description

International patent applications through PCT (Patent Cooperation Treaty) and direct filings to foreign patent offices. Provided to clients seeking global patent protection.

3IP Litigation and Trial Services
CategoryIP Litigation
Description

Legal representation in patent litigation, trials, and disputes before the Korean Patent Trial and Appeal Board and courts. Provided to corporations and research institutions facing IP disputes.

4IP-R&D Strategic Consulting
CategoryIP Strategy Consulting
Description

Strategic consulting services utilizing patent big data analysis to support R&D planning, prevent duplicate research, and maximize R&D efficiency. Includes patent trend analysis, competitive research theme identification, and patent barrier navigation. Provided to corporate R&D teams and research institutions.

5Technology Licensing and Commercialization Consulting
CategoryTechnology Transfer Services
Description

Full-cycle technology transfer and commercialization support from invention counseling to patent registration and technology transfer, including IP investment matching and M&A IP due diligence. Provided to universities, research institutes, and companies seeking to monetize IP assets.

6Utility Model, Design, and Trademark Services
CategoryIP Registration Services
Description

Filing and registration services for utility models, industrial designs, trademarks, and copyrights. Provided to corporate clients and brand owners.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1RESPIRA Pte. Ltd. (Singapore)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-19
Description

Ajou University's Industry-Academic Cooperation Foundation and Singapore RESPIRA signed a License and Material Transfer Agreement for AI-based inhalation capsule technology. Jungjin supported the deal by strategically developing Ajou's natural product patent portfolio. The agreement includes royalties, milestone payments, and material supply, with expected returns exceeding KRW 500 million for Ajou.

jjpat.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-12
Description

Jungjin IP Law Firm signed an MOU with Pusan National University's IP-Centered University Project Group to strengthen cooperation in intellectual property. The partnership aims to promote IP education, enhance patent support services, and foster innovation and IP strategy development for students, researchers, and startups affiliated with the university.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-17
Description

Managing Partner Kim Soon-woong was appointed as Technology Commercialization Advisor for Ajou University. Jungjin has a longstanding relationship supporting Ajou's technology commercialization, including the landmark RESPIRA technology transfer. Jungjin also participates as IP strategy expert in Ajou's MSIT SEED Fast Track program for multifunctional composite materials development.

4Research Development Commercialization Policy Research Association (연구개발사업화정책연구회)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-02-29
Description

Managing Partner Kim Soon-woong participated in the founding of the Research Development Commercialization Policy Research Association, serving as a presenter on shared patent issues in international joint research. The association aims to improve Korea's technology commercialization ecosystem through policy research and legislative support.

jjpat.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-04
Description

Jungjin's Managing Partner Kim Soon-woong serves as Vice Chair of the IP Overseas Cooperation Committee of KAIPS. In this role, he participated in the China-Korea IP Service Industry Conference in Beijing (2023) and led cooperation efforts with international IP service associations and firms.

6Beijing IP Service Association
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-09-04
Description

MOU signed between KAIPS and Beijing IP Service Association at the Beijing IP Service Industry Development Forum. Aims to strengthen cooperation between Korean and Chinese IP service industries and promote IP protection and service exports.

jjpat.com
7Jungjin IP Strategy Institute (정진지식재산전략연구소)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Jungjin IP Strategy Institute is the affiliated consulting arm of Jungjin IP Law Firm, established in 2020 to provide advanced IP strategy and commercialization consulting. It supports the parent firm in delivering full-cycle IP services from technology discovery to commercialization for universities, companies, and research institutions.

jjpat.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Jungjin actively participates in the Korea Technology Commercialization Association's events and initiatives. Managing Partner Kim presented on technology transfer strategies at the 1st Technology Commercialization Innovation Forum (May 2024) and 2025 Korea Tech Festival. The firm is also involved in the association's SPC establishment initiative for private-led technology commercialization.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Korean full-service law firm with substantial IP practice covering patent prosecution, FTO analysis, IP litigation, and licensing. Comparable to Jungjin in offering Korean IP services with biotech expertise, but operates at much larger scale with broader international reach.

2AST IP (formerly ASTORIA)
TypeDirect peer
Description

Korean IP boutique firm with strong biotechnology and pharmaceutical patent prosecution capabilities and technology commercialization support. Directly comparable to Jungjin in biotech IP boutique positioning and Korean market focus.

TypeDirect peer
Description

Korean IP boutique law firm specializing in patent prosecution, IP litigation, and IP strategy with notable biotech and pharmaceutical expertise. Closest comparable to Jungjin in terms of IP boutique positioning, biotech specialization, and practice focus.

TypeBroad incumbent
Description

Korean full-service law firm with a notable IP practice including patent prosecution, IP litigation, and biotech/life sciences work. Comparable to Jungjin in offering Korean IP services across technical fields including biotech, but at significantly larger firm scale.

TypeBroad incumbent
Description

Korea's largest full-service law firm with a leading intellectual property practice covering prosecution, litigation, licensing, and technology transfer across all technical fields including biotech. Comparable to Jungjin as a domestic Korean IP services competitor with significantly broader resources, international network, and headcount.

TypeBroad incumbent
Description

Leading global IP law firm widely regarded as the top U.S. firm for biotech and pharmaceutical patent prosecution and litigation. Comparable to Jungjin in deep biotech specialization and serves as a benchmark for international expansion of biotech IP practices.

TypeDirect peer
Description

Korean IP boutique law firm with strong biotech and pharmaceutical patent prosecution and litigation practice, plus university technology transfer support. Comparable to Jungjin in firm size, biotech specialization, and service mix.

TypeEmerging player
Description

U.S. patent prosecution boutique with renowned biotechnology and pharmaceutical patent practice and deep PTAB/UPC litigation capabilities. Comparable to Jungjin in focused biotech patent specialization though differs in its U.S.-centric geographic focus.

TypeBroad incumbent
Description

Premier global IP boutique law firm with leading biotech and pharmaceutical patent practice plus technology transfer expertise. Comparable to Jungjin in IP-boutique positioning and biotech/life sciences technology transfer focus, though operating globally with substantially larger scale.

10DAEKYUNG IP (대경특허법률법인)
TypeDirect peer
Description

Korean patent law firm with comprehensive patent prosecution and IP strategy services covering chemistry, biotech, and mechanical fields. Comparable to Jungjin as a direct domestic Korean IP boutique with multi-disciplinary technical expertise and prosecution focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JUNGJIN International Intellectual Property Law Firm

Intellectual Property Law Servicesjjpat.com

JUNGJIN International Intellectual Property Law Firm is a Seoul-based IP law firm specializing in patent/trademark prosecution, IP-R&D consulting, FTO analysis, and technology transfer, serving biotech/pharma companies, universities, and research institutes across Korea.

What JUNGJIN International Intellectual Property Law Firm does

JUNGJIN International Intellectual Property Law Firm (특허법인 정진) is a Seoul-based intellectual property law firm founded in 2006 by Managing Partner Kim Soon-woong, a former Director of Technology Transfer at Seoul National University R&DB Foundation. The firm specializes in patent and trademark prosecution, IP-R&D strategic consulting, Freedom-to-Operate (FTO) analysis, technology valuation, and technology transfer commercialization. Approximately 72% of its practice is concentrated in the biotechnology and pharmaceutical sectors, and roughly 80% of clients are universities, national research institutes, startups, and SMEs. Since inception, the firm has handled more than 12,000 patent and trademark filings and has sustained technology transfer outcomes exceeding KRW 1 billion annually since 2016, with notable transactions including the 2021 KRIBB NK Cell technology transfer valued at KRW 150 billion and the 2026 Ajou University-RESPIRA Singapore licensing deal for AI-based inhalation capsule technology.

The firm's service portfolio is organized around five practice areas: Patent Prosecution, Overseas/PCT Filing, Litigation/Trials, IP-R&D Strategic Consulting, and Technology Licensing/Commercialization Consulting. It is differentiated by patent big-data-driven IP-R&D methodology, a multidisciplinary team of patent attorneys and technical specialists (veterinarians, pharmacists, biologists, chemists, and engineers), and a wholly-owned consulting subsidiary, the Jungjin IP Strategy Institute (정진지식재산전략연구소), established in 2020. The firm maintains anchor relationships with 40+ Korean universities and 10+ national research institutes and counts EuBiologics, CJ, SCD Pharmaceutical, Quratis, Asan Medical Center, Samsung Medical Center, KRIBB, and the National Marine Biodiversity Institute of Korea among its named clients.

Commercial operations are anchored in a single Seoul headquarters in Guro-gu, with revenue generated through engagement-based professional services fees, patent prosecution retainers, and success-based technology transfer and IP financial services. Marketing and lead generation are driven by thought-leadership columns in IP trade publications, a weekly pharma/biotech IP Issue Clip newsletter, and active participation in domestic and international events such as INTA, the INTERBIZ Bio Partnering Forum, and KAIPS bilateral IP forums. In November 2025, the firm was officially designated as a Technology Transfer Institution by the Minister of Trade, Industry and Energy, and it remains a registered consulting organization for the Korea IP Protection Agency's Pharmaceutical Patent Strategy Support Program (since 2022). Headcount has grown from 18 to 40+ professionals between the firmographic snapshot and late 2024/early 2025, with additional senior technical hires planned for 2026.

JUNGJIN International Intellectual Property Law Firm firmographics

Firmographics
Name
JUNGJIN International Intellectual Property Law Firm
Legal name
특허법인 정진
Website
https://jjpat.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
JUNGJIN International Intellectual Property Law Firm is a Seoul-based IP law firm specializing in patent/trademark prosecution, IP-R&D consulting, FTO analysis, and technology transfer, serving biotech/pharma companies, universities, and research institutes across Korea.
Ownership category
akta.pro rank

JUNGJIN International Intellectual Property Law Firm industry classification

Industry
Product category
Intellectual Property Law Services
NAICS
Legal Services (5411)
SIC
Services-Legal Services (8111)
akta.pro industry
PRIMARYBPAHAMAA
Patent Prosecution & Portfolio Management
SECONDARYBPAHAMAF
IP Licensing, Transactions & Technology Transfer
SECONDARYBPAHAMAJ
IP Filing, Annuities & Renewals Administration
SECONDARYBPAHAMAI
IP Search, Watch & Competitive Intelligence

Keywords

  • Patent prosecution services
  • IP strategy consulting
  • Patent litigation
  • Intellectual property law
  • Technology transfer services

Where JUNGJIN International Intellectual Property Law Firm is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

JUNGJIN International Intellectual Property Law Firm business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Patent and Trademark Filing Services: Domestic and international patent, utility model, design, and trademark prosecution and registration services.
  2. IP-R&D and Technology Commercialization Consulting: Strategic IP consulting, FTO analysis, patent portfolio construction, and technology transfer services. Technology transfer outcomes have exceeded KRW 1 billion annually since 2016.
  3. IP Financial Services: Technology valuation, IP investment matching, M&A IP due diligence, and unused patent identification and transfer services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

JUNGJIN International Intellectual Property Law Firm product offering

Product offering

Core offering

JUNGJIN is a Korean IP law firm providing full-cycle intellectual property services including domestic and international patent and trademark prosecution, PCT/overseas filing, IP litigation and trials, IP-R&D strategic consulting using patent big data analytics, and technology licensing and commercialization. The firm specializes in biotech and pharmaceutical sectors (72% of practice) and serves universities, national research institutes, and biotech/pharma companies with deep technical expertise and end-to-end IP support from R&D planning through technology transfer.

Product overview

JUNGJIN IP Law Firm is an IP services firm offering a comprehensive portfolio of intellectual property services organized around five core practice areas: Patent Prosecution, Overseas/PCT Filing, Litigation/Trials, IP-R&D Strategic Consulting, and Technology Licensing Consulting. The firm operates specialized teams across biotechnology, chemistry, mechanical engineering, electronics, trademarks, and design. Its subsidiary, the Jungjin IP Strategy Institute, provides advanced IP strategy consulting and operates alongside the law firm to deliver full-cycle IP solutions. The firm is particularly strong in bio/pharmaceutical IP (approximately 72% of practice) and was officially designated as a Technology Transfer Institution by the Ministry of Trade, Industry and Energy in November 2025, enabling it to lead IP-based technology transfer, commercialization, and activation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patent Prosecution Services Comprehensive patent filing, prosecution, and registration services covering domestic and international patent applications. Provided to universities, research institutes, biotech/pharma companies, and SMEs.
  • Overseas/PCT Filing Services International patent applications through PCT (Patent Cooperation Treaty) and direct filings to foreign patent offices. Provided to clients seeking global patent protection.
  • IP Litigation and Trial Services Legal representation in patent litigation, trials, and disputes before the Korean Patent Trial and Appeal Board and courts. Provided to corporations and research institutions facing IP disputes.
  • IP-R&D Strategic Consulting Strategic consulting services utilizing patent big data analysis to support R&D planning, prevent duplicate research, and maximize R&D efficiency. Includes patent trend analysis, competitive research theme identification, and patent barrier navigation. Provided to corporate R&D teams and research institutions.
  • Technology Licensing and Commercialization Consulting Full-cycle technology transfer and commercialization support from invention counseling to patent registration and technology transfer, including IP investment matching and M&A IP due diligence. Provided to universities, research institutes, and companies seeking to monetize IP assets.
  • Utility Model, Design, and Trademark Services Filing and registration services for utility models, industrial designs, trademarks, and copyrights. Provided to corporate clients and brand owners.

Quantifiable outcome

  • Technology transfer revenue exceeding KRW 1 billion annually since 2016
  • +3 more outcomes

Companies that use JUNGJIN International Intellectual Property Law Firm

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles3 records

JUNGJIN International Intellectual Property Law Firm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

JUNGJIN International Intellectual Property Law Firm partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • RESPIRA Pte. Ltd. (Singapore)coreStrategic or Co-development Partner · 19 March 2026Ajou University's Industry-Academic Cooperation Foundation and Singapore RESPIRA signed a License and Material Transfer Agreement for AI-based inhalation capsule technology. Jungjin supported the deal by strategically developing Ajou's natural product patent portfolio. The agreement includes royalties, milestone payments, and material supply, with expected returns exceeding KRW 500 million for Ajou.
  • Pusan National University IP-Centered University Project GroupcoreStrategic or Co-development Partner · 12 July 2024Jungjin IP Law Firm signed an MOU with Pusan National University's IP-Centered University Project Group to strengthen cooperation in intellectual property. The partnership aims to promote IP education, enhance patent support services, and foster innovation and IP strategy development for students, researchers, and startups affiliated with the university.
  • Ajou UniversitycoreStrategic or Co-development Partner · 17 June 2024Managing Partner Kim Soon-woong was appointed as Technology Commercialization Advisor for Ajou University. Jungjin has a longstanding relationship supporting Ajou's technology commercialization, including the landmark RESPIRA technology transfer. Jungjin also participates as IP strategy expert in Ajou's MSIT SEED Fast Track program for multifunctional composite materials development.
  • Research Development Commercialization Policy Research Association (연구개발사업화정책연구회)minorStrategic or Co-development Partner · 29 February 2024Managing Partner Kim Soon-woong participated in the founding of the Research Development Commercialization Policy Research Association, serving as a presenter on shared patent issues in international joint research. The association aims to improve Korea's technology commercialization ecosystem through policy research and legislative support.
  • Korea Intellectual Property Service Association (KAIPS) IP Overseas Cooperation CommitteecoreStrategic or Co-development Partner · 4 September 2023Jungjin's Managing Partner Kim Soon-woong serves as Vice Chair of the IP Overseas Cooperation Committee of KAIPS. In this role, he participated in the China-Korea IP Service Industry Conference in Beijing (2023) and led cooperation efforts with international IP service associations and firms.
  • Beijing IP Service AssociationminorStrategic or Co-development Partner · 4 September 2023MOU signed between KAIPS and Beijing IP Service Association at the Beijing IP Service Industry Development Forum. Aims to strengthen cooperation between Korean and Chinese IP service industries and promote IP protection and service exports.
  • Jungjin IP Strategy Institute (정진지식재산전략연구소)coreStrategic or Co-development PartnerJungjin IP Strategy Institute is the affiliated consulting arm of Jungjin IP Law Firm, established in 2020 to provide advanced IP strategy and commercialization consulting. It supports the parent firm in delivering full-cycle IP services from technology discovery to commercialization for universities, companies, and research institutions.
  • Korea Technology Commercialization Association (한국기술사업화협회)coreStrategic or Co-development PartnerJungjin actively participates in the Korea Technology Commercialization Association's events and initiatives. Managing Partner Kim presented on technology transfer strategies at the 1st Technology Commercialization Innovation Forum (May 2024) and 2025 Korea Tech Festival. The firm is also involved in the association's SPC establishment initiative for private-led technology commercialization.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

JUNGJIN International Intellectual Property Law Firm competitors and assessment

Company assessment

Broad incumbents

  • Lee & Ko IP Group (LEE & KO): Korean full-service law firm with substantial IP practice covering patent prosecution, FTO analysis, IP litigation, and licensing. Comparable to Jungjin in offering Korean IP services with biotech expertise, but operates at much larger scale with broader international reach.
  • Yoon & Yang (formerly Yoon Yang Kim Shin & Yu): Korean full-service law firm with a notable IP practice including patent prosecution, IP litigation, and biotech/life sciences work. Comparable to Jungjin in offering Korean IP services across technical fields including biotech, but at significantly larger firm scale.
  • KIM & CHANG: Korea's largest full-service law firm with a leading intellectual property practice covering prosecution, litigation, licensing, and technology transfer across all technical fields including biotech. Comparable to Jungjin as a domestic Korean IP services competitor with significantly broader resources, international network, and headcount.
  • Fish & Richardson: Leading global IP law firm widely regarded as the top U.S. firm for biotech and pharmaceutical patent prosecution and litigation. Comparable to Jungjin in deep biotech specialization and serves as a benchmark for international expansion of biotech IP practices.
  • Finnegan: Premier global IP boutique law firm with leading biotech and pharmaceutical patent practice plus technology transfer expertise. Comparable to Jungjin in IP-boutique positioning and biotech/life sciences technology transfer focus, though operating globally with substantially larger scale.

Direct peers

  • AST IP (formerly ASTORIA): Korean IP boutique firm with strong biotechnology and pharmaceutical patent prosecution capabilities and technology commercialization support. Directly comparable to Jungjin in biotech IP boutique positioning and Korean market focus.
  • Y.P. Lee & Partners (YP): Korean IP boutique law firm specializing in patent prosecution, IP litigation, and IP strategy with notable biotech and pharmaceutical expertise. Closest comparable to Jungjin in terms of IP boutique positioning, biotech specialization, and practice focus.
  • HMP Law (formerly Y.S. Chang & Associates): Korean IP boutique law firm with strong biotech and pharmaceutical patent prosecution and litigation practice, plus university technology transfer support. Comparable to Jungjin in firm size, biotech specialization, and service mix.
  • DAEKYUNG IP (대경특허법률법인): Korean patent law firm with comprehensive patent prosecution and IP strategy services covering chemistry, biotech, and mechanical fields. Comparable to Jungjin as a direct domestic Korean IP boutique with multi-disciplinary technical expertise and prosecution focus.

Emerging players

  • Sterne Kessler: U.S. patent prosecution boutique with renowned biotechnology and pharmaceutical patent practice and deep PTAB/UPC litigation capabilities. Comparable to Jungjin in focused biotech patent specialization though differs in its U.S.-centric geographic focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

JUNGJIN International Intellectual Property Law Firm social profiles

Digital presence

JUNGJIN International Intellectual Property Law Firm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JUNGJIN International Intellectual Property Law Firm leadership team

Management profile

Number of profiles

Profiles7 records

JUNGJIN International Intellectual Property Law Firm subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

JUNGJIN International Intellectual Property Law Firm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JUNGJIN International Intellectual Property Law Firm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JUNGJIN International Intellectual Property Law Firm

What does JUNGJIN International Intellectual Property Law Firm do?

JUNGJIN is a Korean IP law firm providing full-cycle intellectual property services including domestic and international patent and trademark prosecution, PCT/overseas filing, IP litigation and trials, IP-R&D strategic consulting using patent big data analytics, and technology licensing and commercialization. The firm specializes in biotech and pharmaceutical sectors (72% of practice) and serves universities, national research institutes, and biotech/pharma companies with deep technical expertise and end-to-end IP support from R&D planning through technology transfer.

Is JUNGJIN International Intellectual Property Law Firm a public or private company?

JUNGJIN International Intellectual Property Law Firm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was JUNGJIN International Intellectual Property Law Firm founded?

JUNGJIN International Intellectual Property Law Firm was founded in 2006. It employs 11 to 50 people.

Where is JUNGJIN International Intellectual Property Law Firm based?

JUNGJIN International Intellectual Property Law Firm is headquartered in Seoul, South Korea, in the Asia region.

How does JUNGJIN International Intellectual Property Law Firm make money?

Three revenue lines are on record. Patent and Trademark Filing Services are the primary driver. The others are IP-R&D and Technology Commercialization Consulting and IP Financial Services.

Who are JUNGJIN International Intellectual Property Law Firm's main competitors?

Broad incumbents on record are Lee & Ko IP Group (LEE & KO), Yoon & Yang (formerly Yoon Yang Kim Shin & Yu), KIM & CHANG, Fish & Richardson and Finnegan. Direct peers are AST IP (formerly ASTORIA), Y.P. Lee & Partners (YP), HMP Law (formerly Y.S. Chang & Associates) and DAEKYUNG IP (대경특허법률법인). Sterne Kessler is listed as an emerging player.

Does JUNGJIN International Intellectual Property Law Firm have an API?

No public API is recorded for JUNGJIN International Intellectual Property Law Firm.

What industry is JUNGJIN International Intellectual Property Law Firm in?

JUNGJIN International Intellectual Property Law Firm's product category is Intellectual Property Law Services. Its primary akta.pro industry code is BPAHAMAA, Patent Prosecution & Portfolio Management, with a secondary code of BPAHAMAF, IP Licensing, Transactions & Technology Transfer. Its NAICS code is 5411 and its SIC code is 8111.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales